Riskpilot← Back to searchSign inGet full accessHuddinge apotek AB
ABActiveOrg 5592460157Fittja Torg 21Retail sale of pharmaceutical products · NACE 4773Est. 20203 employees
Revenue 2025
SEK 14,1M
+9% vs 2024
EBITDA margin
2.0%
-8% vs 2024
Equity ratio
18.0%
Financial strength
Net profit 2025
SEK 127K
+27% vs 2024
| Revenue | SEK 14,1M | +9% |
| EBITDA | SEK 288K | -8% |
| Net profit | SEK 127K | +27% |
| Total assets | SEK 3,2M | +0% |
| Equity | SEK 576K | +28% |
| Employees | 3 | — |
Legal name
Huddinge apotek AB
Org number
5592460157
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
3 mars 2020
Share capital
SEK 25 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget har till föremål för sin verksamhet att bedriva handel med receptbelagda apoteksvaror, receptfria apoteksvaror och handelsvaror som lämpar sig för försäljning och distribution till konsumenter genom apotek samt därmed förenlig verksamhet.
Address
Fittja Torg 21
Email
info@apoteketsatra.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 7 373 | 11 950 | 12 916 | 14 089 |
| Staff expenses | — | −580 | −1 827 | −2 002 | −2 054 |
| EBITDA | −55 | 545 | 326 | 314 | 288 |
| Depreciation & amort. | −0 | −45 | −69 | −69 | −41 |
| EBIT | −55 | 500 | 257 | 244 | 246 |
| Net financials | — | −64 | −103 | −78 | −35 |
| Profit before tax | −55 | 347 | 119 | 127 | 161 |
| Tax | −0 | −62 | −25 | −27 | −34 |
| Net profit | −55 | 285 | 94 | 100 | 127 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 395 | 3 032 | 3 106 | 3 199 | 3 200 |
| Equity | 20 | 304 | 349 | 449 | 576 |
| Long-term debt | 374 | 2 214 | 1 506 | 1 339 | 791 |
| Short-term debt | 1 | 424 | 1 126 | 1 247 | 1 618 |
| Total debt | 375 | 2 638 | 2 632 | 2 586 | 2 409 |
EBITDA margin
2.0%
This company
15.8%
Market median
-87% vs market
20212025
Equity ratio
18.0%
This company
38.2%
Market median
-53% vs market
20212025
Return on equity
22.1%
This company
18.4%
Market median
+20% vs market
20212025
Net profit margin
0.9%
This company
8.1%
Market median
-89% vs market
20212025
Asset turnover
4.40×
This company
1.12×
Market median
+293% vs market
20212025
Debt / equity
4.56×
This company
0.62×
Market median
-635% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Deputy Board Member | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MATTI-FARMA AB
Huddinge apotek AB Board members of Huddinge apotek AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Asaad Abdulsalam Khaleel Al Zubaydi | Deputy Board Member | 0 companies |
| Talin Murad | Board of Directors | 0 companies |
| Matti Yousef Yacob | Board of Directors | 0 companies |
| Zayn Alabideen Al Zubaydi | Deputy Board Member | 0 companies |